Viewing Study NCT04008251


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2026-02-07 @ 7:11 PM
Study NCT ID: NCT04008251
Status: UNKNOWN
Last Update Posted: 2019-08-07
First Post: 2019-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Humanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies
Sponsor: Wuhan Sian Medical Technology Co., Ltd
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia View
None B Cell Lymphoma View
Keywords: